Speed-to-the-Market 

In the city of Wuhan there are more than 360 biomedical enterprises. 15 of these enterprises are listed on the stock market and 18 get the turnover of more than 0.1 billion RMB. The largest of these companies include Cargill Alking Bioengineering Co.,Ltd (this company is now called CABIO), Wuhan Jianmin Pharmaceutical Group Co.,Ltd, Wuhan Mayinglong Pharmaceutical Co.,Ltd, Wuhan Humanwell Hi-Tech Industry Co.,Ltd and several others that will be mentioned on the website. In general, the main market-entrance barriers are registration and certification, intellectual property rights, production location screening and sales and marketing structures. For all these bariers, IMTT provides services to overcome them.